Zeus Sleep has been awarded £1.48 million of funding from the National Institute for Health and Care Research (NIHR) to run one of the UK’s largest multi-centre clinical trials in Obstructive Sleep Apnoea (OSA).

With the trial is being led by Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, new research by Zeus has found that over half of adults (56%) reveal snoring either significantly or slightly impacts their life, offering fresh hope to millions suffering from sleep disruption due to chronic snoring.

This comes as the company’s first consumer product, a discreet anti-snoring device, is already available in the UK and helping poor sleepers and their partners.